Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

    NEXT STORY
    The 2019 U.S. HIV Market: Analyses & Forecasts Through 2014-2024
    PREV STORY
    AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunodiagnostic Market to exhibit a CAGR of 4.7% and Reach USD 22,732.7 Million by 2025, Increasing Awareness for Quality Healthcare Services to Fuel Demand, says Fortune Business Insights

    author_avatar
    NASDAQ Market News

    NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program

    AMES, Iowa, Nov. 02, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated ...

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program

    author_avatar
    NASDAQ Market News